Raziel Therapeutics
2012
FOUNDED
PRIVATE
STATUS
Series C
LATEST DEAL TYPE
$22M
LATEST DEAL AMOUNT
10
INVESTORS
Description
Operator of a pharmaceutical firm intended to develop drugs for submental fat, and fat disorders such as Dercum's disease. The company's drug single injection treatment into subcutaneous fat causes immediate fat cell death at the injection site, enabling patients to a significant reduction of fat tissue for long time periods without any invasive procedures.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- Prof. Menahem Plaut Street 10
- Rehovot
- Israel
+972 00-000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Raziel Therapeutics’s full profile, request a free trial.
Raziel Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 18-Dec-2019 | $22M | 000.00 | Completed | Clinical Trials - Phase 2 | |
| 2. Early Stage VC (Series A) | 25-Feb-2016 | 00.00 | 00.00 | Completed | Clinical Trials - Phase 1 | |
| 1. Seed Round | 01-Feb-2016 | $600K | $600K | Completed | Clinical Trials - Phase 1 |
Raziel Therapeutics Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Catalyst Fund | Impact Investing | Minority | 000 0000 | 000000 0 | ||
| Peregrine Investments | Fund of Funds | Minority | 000 0000 | 000000 0 | ||
| Quark Venture | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Wille Finance | Family Office | Minority | 000 0000 | 000000 0 | ||
| Avi Meisler | Angel (individual) | Minority | 000 0000 | 000000 0 |
Raziel Therapeutics Executive Team (1)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Alon Bloomenfeld | Chief Executive Officer |
Raziel Therapeutics Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Philippe Schaison | Raziel Therapeutics | Chairman | 000 0000 | |
| Tomer Cribb | Raziel Therapeutics | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 2 of 3 board members. Get the full list »